Three-Ring Dance for Antitumor Agent

  • Author: Vikki Cantrill
  • Published: 19 December 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: The Journal of Organic Chemistry/ACS Publications
  • Associated Societies: American Chemical Society (ACS), USA
thumbnail image: Three-Ring Dance for Antitumor Agent

(±)-Streptonigrin (pictured) is a potent broad-spectrum anticancer antibiotic. Although the drug reached phase II clinical trials in the late 1970s, trials were stopped owing to its toxicity. Despite this fact, there is still considerable interest in this area because analogues of streptonigrin may be less toxic but equally effective as anticancer agents.


Timothy Donohoe and colleagues, University of Oxford, UK, and Federal University of Minas Gerais, Brazil, planned a convergent route, in which three fragments are formed before being joined together to create the tetracyclic core of streptonigrin. Two routes were devised and both rely on a ring-closing metathesis reaction to form one of the nitrogen-containing (pyridine) rings, and a challenging (Suzuki−Miyaura) coupling reaction. The shorter of the sequences gave streptonigrin in 14 steps and 11 % overall yield.

A convergent approach is attractive because it provides good opportunities for various analogues to be formed. Each of the three fragments may be derivatized before being joined together. The team hopes this route will facilitate the synthesis of a library of streptonigrin analogues for biological evaluation.


Article Views: 2335

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


CONNECT:

ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter


A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH